StreetAlpha.app
Home › Stocks › PFE

Pfizer Inc (PFE)

Healthcare
$27.40
▼ −0.51%
LAST CLOSE · NOV 20

Pfizer is a pharmaceutical and biotechnology company based in New York that develops and sells medicines and vaccines. It last closed at $27.40 on Nov 20, down 0.51% on the day. The next earnings report for PFE is expected around Tue, Feb 2, 2027. For the quarter ended Sep 2026, PFE reported EPS of $0.56 on revenue of $16.58B, with revenue down 0.4% from a year ago. Over its last 8 reports the stock moved an average of 2.3% the session after earnings. Over the last 12 months PFE insiders bought $3.0M of stock on the open market and sold $135K, according to SEC Form 4 filings.

AI Auto Pilots
Is PFE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PFE.

Key Stats

Last 12 months
Results
Revenue
$63.6B
+1.3% vs a year ago
Net income
$4.0B
−59.0% vs a year ago
EPS (diluted)
$0.70
−59.3% vs a year ago
Free cash flow
$11.8B
18.5% margin
Valuation
Market cap
$156B
5.70B shares
P/E
39.1
Price over 12 month EPS
Price to sales
2.5
Market cap over revenue
Dividend yield
6.28%
$1.72 a share over 12 months
Balance sheet
Cash & equivalents
$1.8B
At Sep 27
Debt
$62.6B
At Sep 27
Shareholder equity
$89.0B
Shares outstanding
5.70B
At Oct 28
CEOAlbert Bourla
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $81.3B$81.3BFY2021FY2022: $101B$101BFY2022FY2023: $59.6B$59.6BFY2023FY2024: $63.6B$63.6BFY2024FY2025: $62.6B$62.6BFY2025

From PFE's SEC filings, latest 10-Q for the period ending Sep 27, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Next report
Feb 2
Estimated date · Time not announced
Reported EPS
$0.56
Quarter ended Sep 2026
Year ago EPS
$0.62
−9.7% on a GAAP basis
Revenue
$16.58B
−0.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.07Dec '24Mar 2025: $0.52Mar '25Jun 2025: $0.51Jun '25Sep 2025: $0.62Sep '25Dec 2025: -$0.29Dec '25Mar 2026: $0.47Mar '26Jun 2026: -$0.04Jun '26Sep 2026: $0.56Sep '26Latest $0.56
Revenue by quarter
Dec 2024: $17.76BDec '24Mar 2025: $13.71BMar '25Jun 2025: $14.65BJun '25Sep 2025: $16.65BSep '25Dec 2025: $17.56BDec '25Mar 2026: $14.45BMar '26Jun 2026: $15.03BJun '26Sep 2026: $16.58BSep '26Latest $16.58B
How PFE moved after its last 8 reports
Average move the session after a report ±2.3%
Nov 3, 2026Time not announced−2.2%
Aug 4, 2026Time not announced+1.5%
May 5, 2026Time not announced+0.6%
Feb 3, 2026Time not announced−3.3%
Nov 4, 2025Time not announced−1.5%
Aug 5, 2025Time not announced+5.2%
Apr 29, 2025Time not announced+3.2%
Feb 4, 2025Time not announced−1.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on PFEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on PFE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PFE

Technical Analysis

PFE · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 7% below its 20 day and 5% below its 50 day average. It is 1% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 32), near oversold. The nearest support is the swing low (Sep 15) at $27.25, and the nearest resistance the 100 day average at $27.54.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 2.5%/day
Key levels
$31.4452 week high+14.7%
$29.3220 day average+7.0%
$28.8250 day average+5.2%
$28.19Swing high (Sep 14)+2.9%
$27.89Pivot R1+1.8%
$27.62Pivot+0.8%
$27.54100 day average+0.5%
$27.40Last close
$27.25Swing low (Sep 15)−0.5%
$27.13Pivot S1−1.0%
$27.03200 day average−1.4%
$23.6252 week low−13.8%
Indicators
RSI (14)32.45Weak, oversold below 30Neutral
MACD-0.33Below its signal lineBearish
Stochastic1.8Near the bottom of its rangeOversold
ADX (14)19.3No clear trend
Williams %R-98.8Oversold below −80, overbought above −20Oversold
CCI (20)-162.6Oversold below −100, overbought above 100Oversold
Rate of change−6.8%Change over 10 sessionsBearish
ATR (14)$0.67Typical daily range, 2.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for PFE

What happened before

See how PFE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PFE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PFE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PFEHow many large options trades hit PFE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

PFE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●1,339 buying vs 1,331 selling
  • ▼Held by funds -1.1 pts
  • ▲Funds holding +73
  • ▲Superinvestors: 3 added, 1 cut
  • ▼Put/call 0.62 to 1.21
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,9252,852+2.6%
In funds' top 103421+61.9%
Held by funds66.2%67.3%−1.1 pts
New / increased231 / 1,108121 / 1,132+6.9%
Reduced / sold out1,199 / 1321,205 / 237−7.7%
Put/call ratio1.210.62+94.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PFE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

PFE Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$3.0M3 buys · 3 insiders
Sold$135K2 sales · 1 insider
Cluster buy: 3 insiders bought $3.0M between Aug 5 and Aug 12.
2026-06 sold $51K2026-08 bought $3.0M2026-08 sold $83KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 12Albert BourlaChairman & CEOBuy38,000$26.34$1.0M
Aug 5Jennifer B. DamicoSVP & ControllerSale3,278$25.40$83K
Aug 5Mortimer J BuckleyDirectorBuy37,632$25.52$960K
Aug 5Ronald E BlaylockDirectorBuy39,231$25.46$999K
Jun 9Jennifer B. DamicoSVP & ControllerSale2,000$25.70$51K
Mar 4, 2025Jennifer B. DamicoSVP & ControllerSale2,500$25.93$65K
Every insider buy and sale for PFE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See PFE insider trades →

From SEC Form 4 filings by PFE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

PFE Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$3.3B
2.1% of value
Shares outstanding, 12 months
+0.2%
More shares
Last quarter
$1.4M
Sep 2026
Avg price paid, last quarter
$26.18
55K shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $268.9M
Dec 2023: $1.6M, average price $30.27Mar 2024: $268.9M, average price $27.67Jun 2024: $2.1M, average price $27.62Sep 2024: $2.8M, average price $29.16Dec 2024: $3.6M, average price $27.35Mar 2025: $244.7M, average price $26.24Jun 2025: $1.9M, average price $23.88Sep 2025: $1.7M, average price $24.54Dec 2025: $3.4M, average price $25.27Mar 2026: $179.5M, average price $27.07Jun 2026: $3.7M, average price $26.89Sep 2026: $1.4M, average price $26.18
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 3, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PFE is in one of them and how their past PFE trades turned out.

PFE in the AI portfolios
Loading…

PFE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PFE in an article yet. Here's the latest on the wider market.

PFE in the news

PFE Congress Trades

All congress trades →
Trades, 12 months
14
Buys
6
43%
Sells
8
57%
People
8
Last filed Nov 5
Who traded PFE · since 2014
Latest 5 filings of 302
$15K – $50KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 25, 2026Filed Oct 7, 2026
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$15K – $50KTraded Sep 4, 2026Filed Oct 7, 2026
$15K – $50KTraded Mar 10, 2025Filed Aug 13, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$15K – $50KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KSep 25, 2026Oct 7, 202612 d
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Ro KhannaD · CASell$15K – $50KSep 4, 2026Oct 7, 202633 d
Carol Devine MillerR · WVSell$15K – $50KMar 10, 2025Aug 13, 2026521 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Pfizer

Pfizer is a pharmaceutical and biotechnology company headquartered in New York. It researches, develops, makes and sells medicines and vaccines, including Eliquis, Comirnaty and Paxlovid, along with biosimilar versions of biologic medicines. Its work spans areas such as oncology and obesity. Its customers include pharmacy chains, wholesalers, healthcare providers, government payors and patients in markets around the world.

Headquarters
New York, NY
Founded
1849